Investment Type: Venture Capital
Investment Stage: Series B
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 26.04.2023 | Evommune | evommune.com | $405.5M | United Sta... |
| 18.11.2022 | Lucy Thera... | lucytherapeutics.com | $12.5M | United Sta... |
| 05.11.2022 | ARKUDA The... | arkudatx.com | $108M | United Sta... |
| 05.11.2022 | HotSpot Th... | hotspotthera.com | $210M | United Sta... |
| - | SutroVax | sutrovax.com | $281M | United Sta... |
| - | Vigil Neur... | vigilneuro.com | $255M | United Sta... |
| - | Fusion Pha... | fusionpharma.com | $195.91M | Canada, On... |
| - | Plexium | plexium.com | $225M | United Sta... |
| - | Oculis S.A... | oculis.com | $704.2M | Switzerlan... |
| - | Akouos | akouos.com | $162.5M | United Sta... |
Show more
Mentions in press and media 9
| Date | Title | Description |
| 06.05.2026 | Windward Bio Announces $165 Million Crossover Financing To Advance Long-Acting Immunology Pipeline | Windward Bio, a private, clinical-stage biotechnology company based in Basel, Switzerland, has announced an upsized $165 million crossover financing led by OrbiMed, with participation from RA Capital Management, Janus Henderson Investors, S... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| 07.05.2021 | Oculis closes US$57 million Series C financing | |
| 05.01.2018 | Oculis raises CHF20 million and moves to Switzerland | |
| 04.01.2018 | Oculis Raises $20.3M Series B from Novartis Venture Fund | Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing round of CHF 2... |
| 21.05.2017 | Domain Associates Joins $65M Series B for Iterum | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the development and commercialization of anti-infectives for patients with infectious diseases and other acute illnesses, today announced that it has clo... |
| 21.05.2017 | Iterum Raises $65M Series B | Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the development and commercialization of anti-infectives for patients with infectious diseases and other acute illnesses, today announced that it has clo... |
| 16.03.2017 | Pivotal bioVenture Partners Closes $300M First Life Sciences Fund | San Francisco, CA-based venture capital firm Pivotal bioVenture Partners closed its first fund, at over $300m. Funded by Hong Kong based Nan Fung Group, Pivotal bioVenture Partners Fund I aims to invest in early stage biotechnology companie... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing | Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the completion of a $105 million Series B financing led by Varian and new investo... |